نتایج جستجو برای: mdm2 snp309

تعداد نتایج: 4579  

2015
Kathy L. McGraw Thomas Cluzeau David A. Sallman Ashley A. Basiorka Brittany A. Irvine Ling Zhang P.K. Epling-Burnette Dana E. Rollison Mar Mallo Lubomir Sokol Francesc Solé Jaroslaw Maciejewski Alan F. List

P53 is a key regulator of many cellular processes and is negatively regulated by the human homolog of murine double minute-2 (MDM2) E3 ubiquitin ligase. Single nucleotide polymorphisms (SNPs) of either gene alone, and in combination, are linked to cancer susceptibility, disease progression, and therapy response. We analyzed the interaction of TP53 R72P and MDM2 SNP309 SNPs in relationship to ou...

2017
Guohong Zhou Yajiang Duan Gaoen Ma Wenyi Wu Zhengping Hu Na Chen Yewlin Chee Jing Cui Arif Samad Joanne A. Matsubara Shizuo Mukai Patricia A. D'Amore Hetian Lei

Purpose The murine double minute (MDM)2 is a critical negative regulator of the p53 tumor suppressor, and MDM2 SNP309G is associated with a higher risk of proliferative vitreoretinopathy (PVR); in addition, the MDM2 T309G created using clustered regularly interspaced short palindromic repeats (CRISPR)/associated endonuclease (Cas)9 enhances normal rabbit vitreous-induced expression of MDM2 and ...

Journal: :International journal of clinical and experimental medicine 2015
Jinli Lv Bo Zhu Liang Zhang Qichao Xie Wenlei Zhuo

Previous reports have indicated that MDM2 T309G polymorphism might be a risk factor for various cancers. Increasing studies have been conducted on the association of MDM2 T309G polymorphism with hepatocellular carcinoma (HCC) risk. However, the results remain inconclusive. Thus, the present study aimed to address this controversy by meta-analysis. Relevant literature up to Oct 2014 was searched...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2008
Frank Bartel Juliane Jung Anja Böhnke Elise Gradhand Katharina Zeng Christoph Thomssen Steffen Hauptmann

PURPOSE Although p53 is one of the most studied genes/proteins in ovarian carcinomas, the predictive value of p53 alterations is still ambiguous. EXPERIMENTAL DESIGN We performed analyses of the TP53 mutational status and its protein expression using immunohistochemistry. Moreover, the single nucleotide polymorphism SNP309 in the P2 promoter of the MDM2 gene was investigated. We correlated th...

Journal: :Cancer research 2014
Kathleen I Pishas Susan J Neuhaus Mark T Clayer Andreas W Schreiber David M Lawrence Michelle Perugini Robert J Whitfield Gelareh Farshid Jim Manavis Steve Chryssidis Bronwen J Mayo Rebecca C Haycox Kristen Ho Michael P Brown Richard J D'Andrea Andreas Evdokiou David M Thomas Jayesh Desai David F Callen Paul M Neilsen

Nutlin-3a is a small-molecule antagonist of p53/MDM2 that is being explored as a treatment for sarcoma. In this study, we examined the molecular mechanisms underlying the sensitivity of sarcomas to Nutlin-3a. In an ex vivo tissue explant system, we found that TP53 pathway alterations (TP53 status, MDM2/MDM4 genomic amplification/mRNA overexpression, MDM2 SNP309, and TP53 SNP72) did not confer a...

Journal: :Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010
Xiaoxia Hu Zhengyan Zhang Duanduan Ma Phyllis C Huettner L Stewart Massad Loan Nguyen Ingrid Borecki Janet S Rader

Host genetic variability modifies the risk of cervical cancer in women infected with oncogenic human papillomavirus (HPV). Studies have reported an association of the TP53 codon 72 arginine and cervical cancer, but the results are inconsistent. We examined the association of this single nucleotide polymorphism (SNP) in women with cervical cancer and cervical intraepithelial neoplasia grade 3, u...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید